Emergent Biosolutions Inc (EBS)
Long-Term Debt
$581.80M
Quarterly · Period ending: · USD
EBS Long-Term Debt
Latest reported$581.80Mperiod ending
Latest reported$581.80Mperiod ending
EBS Quarterly Long-Term Debt ($0.00 → $581.80M)
Quarterly long-term debt
High-resolution chart · PNG
EBS long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 581,800,000 | |
| 573,600,000 | |
| 572,100,000 | |
| 663,100,000 | |
| 674,300,000 | |
| 665,700,000 | |
| 673,400,000 | |
| 672,500,000 | |
| 458,500,000 | |
| 459,700,000 | |
| 460,300,000 | |
| 462,800,000 | |
| 461,100,000 | |
| 460,700,000 | |
| 463,300,000 | |
| 1,047,899,999 | |
| 793,600,000 | |
| 824,100,000 | |
| 833,600,000 | |
| 841,800,000 | |
| 851,100,000 | |
| 859,400,000 | |
| 878,100,000 | |
| 879,900,000 | |
| 779,700,000 | |
| 785,600,000 | |
| 820,500,000 | |
| 830,700,000 | |
| 845,000,000 | |
| 744,000,000 | |
| 784,500,000 | |
| 13,495,000 | |
| 13,482,000 | |
| 13,469,000 | |
| 13,500,000 | |
| 248,994,000 | |
| 248,693,000 | |
| 248,394,000 | |
| 248,094,000 | |
| 247,793,000 | |
| 247,393,000 | |
| 247,192,000 | |
| 253,000,000 | |
| 253,000,000 | |
| 253,000,000 | |
| 251,000,000 | |
| 251,000,000 | |
| 251,000,000 | |
| 251,000,000 | |
| 251,000,000 | |
| 62,000,000 | |
| 54,952,000 | |
| 56,069,000 | |
| 57,187,000 | |
| 58,304,000 | |
| 58,866,000 | |
| 58,140,000 | |
| 57,592,000 | |
| 54,094,000 | |
| 48,873,000 | |
| 29,074,000 | |
| 29,657,000 | |
| 30,239,000 | |
| 36,225,000 | |
| 36,910,000 | |
| 44,165,000 | |
| 44,927,000 | |
| 20,500,000 | |
| 21,250,000 | |
| 35,208,000 | |
| 35,935,000 | |
| 0 | |
| 0 | |
| 0 | |
| 42,588,000 | |
| 0 | |
| 0 | |
| 0 | |
| 31,368,000 | |
| 32,555,000 | |
| 10,502,000 | |
| 11,821,000 | |
| 0 | |
| 0 |